Back to Top Skip to main content Skip to sub-navigation

Military Medicine Joining Forces to Fight COVID-19 All Around the World

Image of A group of military personnel posing for a picture. USFJ Surgeon Cell COVID-19, 28 May 2020, USFJ Yokota AB, Japan.

Recommended Content:

Coronavirus | Combat Support

From the onset of the COVID-19 pandemic, the efforts of Navy Medicine’s research and development enterprise (NMR&D) to support everything from outbreak response to laboratory detection and warships to floating hospitals highlights the speed and relevance of military medical and scientific capabilities that help make the U.S. armed forces so strong.

From staffing aboard the Navy’s hospital ships and aircraft carriers to clinical studies at hospitals and in the field, many of Naval Medical Research Center’s (NMRC) staff members were out helping to quash COVID-19 during quarantine. Navy Capt. Charmagne Beckett, senior clinical research medical officer at NMRC’s Infectious Diseases Directorate, deployed within three days of receiving the order to the U.S. Forces Japan (USFJ) where she is now the Assistant Officer in Charge.

The USFJ Surgeon, dual hatted as the U.S. Air Force 374th Medical Group (MDG) Commander, submitted several requests for forces to support the COVID-19 mission. The additional forces allowed the standing up of the Surgeon Cell with the mission "to monitor, prevent, contain, and mitigate the spread of COVID-19 disease through direct action and collaborative efforts to preserve Warfighter readiness by keeping our service members, civilian employees, family members, and our neighboring community healthy, resilient and safe."

Multiple commands from the Navy and Air Force responded to the request with personnel from all over the country, including Walter Reed National Military Medical Center, Naval Hospital Camp Pendleton, Wright Patterson, Randolph Air Force Base (AFB), Randolph AFB, Davis-Monthan AFB, Scott AFB and Naval Medical Center San Diego. Beckett and the 14-member team are providing knowledge, skill sets and capabilities from a variety of disciplines: preventive medicine, infectious diseases, advanced care nursing, medical planning, public health analytics and medical surveillance. Beckett and the Surgeon Cell team are providing direct support and advisement of all COVID-19 related activities.

“We are hopeful that the USFJ Surgeon Cell provides strength to the overall COVID-19 response across Japan’s sub-unified commands. Specifically, at the 374th MDG, clinical research activities were limited prior to COVID-19 but the need to establish access to potential life-saving therapeutics was great thus paving the way for speedy processing of protocol approvals and training,” Beckett said.

The 374th MDG located at Yokota AB, Japan, ensures medical readiness of the 374th Airlift Wing, 5th Air Force, the U.S. Forces Japan Headquarters staff and provides health care, including occupational health, preventive medicine and environmental protection to more than 11,000 personnel.

Working in a new environment even temporarily requires adjustments to professional routines as well as personal. The additional COVID-19 restrictions and requirements do not hinder the work efforts but they can sometimes add to the challenges and no deployment is without challenges.

“The major challenge is the requirement to gather and synthesize the rapidly evolving information regarding COVID-19. We are cautious to avoid missing important information that would threaten to impact operational missions,” Beckett said.

“This mission demands learning and adapting to a joint environment,” she added. “After 26 years on active duty, staying flexible is a personal, life-long lesson that I've continued for this mission. Things change swiftly and constantly – especially with COVID-19.”

Beckett and the Surgeon Cell team are expected to remain in Japan for roughly 170 days and they are already planning redeployments. A new rotation will replace the current team in order to maintain the critical functions. NMR&D has deployed over 30 people to the COVID-19 fight to date.

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: July 17, 2020

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.